CFCThe Compounder Score
PAHC logo

PAHC — Phibro Animal Health Corporation

Drug Manufacturers - Specialty & GenericHealthcare

$35.97

+$0.51 (+1.44%)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.

Market Cap

$1.46B

Forward P/E

9.3x

52-Week Range

N/A

PAHC Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$1.5B

Revenue · FY2026

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$9.9M

FCF · FY2026

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

15.3%

ROCE · FY2026

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

1.3x

Assets ÷ liabilities · FY2026

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

3.9%

CapEx · FY2026

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+0.7%

Dilution · FY2026

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).